ONTOLOGY REPORT - ANNOTATIONS
| Term: | quinolinic acid |
|
| Accession: | CHEBI:16675
|
browse the term
|
| Definition: | A pyridinedicarboxylic acid that has formula C7H5NO4. |
| Synonyms: | exact_synonym: | pyridine-2,3-dicarboxylic acid |
| | related_synonym: | 2,3-Pyridinedicarboxylic acid; C7H5NO4; InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12); InChIKey=GJAWHXHKYYXBSV-UHFFFAOYSA-N; OC(=O)c1cccnc1C(O)=O |
| | alt_id: | CHEBI:26418; CHEBI:44529; CHEBI:8663 |
| | xref_casrn: | 89-00-9 |
| | xref: | Beilstein:137110 "Beilstein Registry Number"; ChEMBL:131911 "ChEMBL COMPOUND"; ChemIDplus:89-00-9 "CAS Registry Number"; DrugBank:DB01796 "DrugBank"; Gmelin:201344 "Gmelin Registry Number"; KEGG COMPOUND:89-00-9 "CAS Registry Number"; KEGG COMPOUND:C03722 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D017378 |
| | xref: | PDBeChem:NTM "PDBeChem" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:46828 |
|
|
quinolinic acid
|
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
affects abundance |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
decreases activity |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases secretion |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases secretion |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Ppif |
peptidylprolyl isomerase F |
|
increases response to substance |
ISO |
16 |
1,292,835 |
1,299,556 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
decreases expression |
EXP |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
Term paths to the root
|